|
Volumn 17, Issue 2, 1996, Pages 179-181
|
Reduction of doxorubicin resistance by tetrandrine and dauricine in harringtonine-resistant human leukemia (HL60) cells
|
Author keywords
cultured tumor cells; dauricine; doxorubicin; drug resistance; drug synergism; harringtonines; leukemia; tetrandrine
|
Indexed keywords
DAURICINE;
DOXORUBICIN;
HARRINGTONINE;
TETRANDRINE;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
CELL COUNT;
CELL CYCLE G2 PHASE;
CELL CYCLE PHASE;
CELL STRAIN HL 60;
COLONY FORMATION;
CONCENTRATION RESPONSE;
CONTROLLED STUDY;
CYTOTOXICITY;
DRUG ACCUMULATION;
DRUG POTENTIATION;
DRUG RESISTANCE;
FLOW CYTOMETRY;
HUMAN;
HUMAN CELL;
LEUKEMIA CELL;
ALKALOIDS;
ANTIBIOTICS, ANTINEOPLASTIC;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
BENZYLISOQUINOLINES;
CELL DIVISION;
DOXORUBICIN;
DRUG RESISTANCE, MULTIPLE;
DRUG RESISTANCE, NEOPLASM;
HARRINGTONINES;
HL-60 CELLS;
HUMANS;
ISOQUINOLINES;
TETRAHYDROISOQUINOLINES;
|
EID: 0029968578
PISSN: 02539756
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (20)
|
References (7)
|